Letters and Corrections1 November 1989Screening for Lung CancerMyron R. Melamed, MD, Betty J. Flehinger, MDMyron R. Melamed, MDSearch for more papers by this author, Betty J. Flehinger, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-111-9-764_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the Editor: We wish to compliment Dr. Eddy (1) on his thoughtful review and evaluation of the lung cancer screening programs that we and others have carried out. However, we come to somewhat different conclusions based on our own analysis of our data.The results of the sputum cytology and chest roentgenogram screening for early lung cancer, derived from the three National Cancer Institute (NCI) supported studies to which Dr. Eddy refers, are not easily amenable to analysis. It is well to bear in mind that all these studies were designed to assess the value of sputum cytology when...References1. Eddy D. Screening for lung cancer. Ann Intern Med. 1989;111:232-7. LinkGoogle Scholar2. FlehingerKimmelMelamed BMM. Natural history of adenocarcinoma-large cell carcinoma of the lung: conclusions from screening programs in New York and Baltimore. JNCI. 1988;80:337-44. CrossrefMedlineGoogle Scholar3. FlehingerKimmel BM. The natural history of lung cancer in a periodically screened population. Biometrics. 1987;43:127-44. CrossrefMedlineGoogle Scholar1. Eddy D. Screening for lung cancer. Ann Intern Med. 1989;111:232-7. LinkGoogle Scholar2. Hulka B. Cancer screening: degrees of proof and practical application. Cancer. 1988;62:1776-80. CrossrefMedlineGoogle Scholar3. MulshineTockmanSmart JMC. Considerations in the development of lung cancer screening tools. JNCI. 1989;81:900-6. CrossrefMedlineGoogle Scholar4. TockmanGuptaMyers MPJ. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol. 1988;6:1685-93. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Thomas J. Watson Research Center Yorktown Heights, NY 10598 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDiagnostic results before and after introduction of autofluorescence bronchoscopy in patients suspected of having lung cancer detected by sputum cytology in lung cancer mass screeningStage I nonsmall cell lung carcinomaLung cancer screening in cigarette smokers in the province of Varese, ItalyEvaluation of a clinic-based screening program for lung cancer with a case-control design in Kanagawa, JapanEARLY DETECTION IN LUNG CANCERScreening for Lung CancerDavid M. Eddy, MD, PhD 1 November 1989Volume 111, Issue 9Page: 764-766KeywordsCancer screeningCell biologyLung and intrathoracic tumorsLung cancer screeningSputumThorax Issue Published: 1 November 1989 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Myron R. Melamed (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: